Low-dose metronomic eribulin in metastatic breast cancer: Is this real metronomic therapy?

被引：0
|
作者：
Altundag, Kadri [1 ]
机构：
[1] MKA Breast Canc Clin, Ankara, Turkey
来源：
JOURNAL OF BUON | 2021年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1174 / 1174
页数：1
相关论文
共 50 条
  • [11] Combination cyclophosphamide - UFT metronomic low-dose chemotherapy for the treatment of metastatic breast cancer: A preclinical analysis
    不详
    BREAST, 2005, 14 : S4 - S5
  • [12] Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer Patients
    Krajnak, Slavomir
    Battista, Marco
    Brenner, Walburgis
    Almstedt, Katrin
    Elger, Tania
    Heimes, Anne-Sophie
    Hasenburg, Annette
    Schmidt, Marcus
    BREAST CARE, 2018, 13 (04) : 272 - 276
  • [13] Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer
    Fedele, P.
    Marino, A.
    Orlando, L.
    Schiavone, P.
    Nacci, A.
    Sponziello, F.
    Rizzo, P.
    Calvani, N.
    Mazzoni, E.
    Cinefra, M.
    Cinieri, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (01) : 24 - 29
  • [14] The Impact of Insulin on Low-dose Metronomic Vinorelbine and Mafosfamide in Breast Cancer Cells
    Krajnak, Slavomir
    Loewe, Amelie
    Battista, Marco Johannes
    Hasenburg, Annette
    Heimes, Anne-Sophie
    Schmidt, Marcus
    Schwab, Roxana
    Brenner, Walburgis
    ANTICANCER RESEARCH, 2021, 41 (03) : 1243 - 1250
  • [15] Metronomic therapy for breast cancer
    Kaur H.
    Budd G.T.
    Current Oncology Reports, 2004, 6 (1) : 49 - 52
  • [16] Metronomic Chemotherapy for Metastatic Breast Cancer
    Krajnak, Slavomir
    Battista, Marco J.
    Hasenburg, Annette
    Schmidt, Marcus
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (1-2) : 10 - 17
  • [17] Safety and efficacy of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast
    Fedele, P.
    Orlando, L.
    Schiavone, P.
    Rizzo, P.
    Calvani, N.
    D'Amico, M.
    Marino, A.
    Sponziello, F.
    Cinieri, A. Nacci e S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [18] Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy
    Munoz, R
    Shaked, Y
    Bertolini, F
    Emmenegger, U
    Man, S
    Kerbel, RS
    BREAST, 2005, 14 (06): : 466 - 479
  • [19] Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study
    S. Krajnak
    C. Schnatz
    K. Almstedt
    W. Brenner
    F. Haertner
    A.-S. Heimes
    A. Lebrecht
    G.-M. Makris
    R. Schwab
    A. Hasenburg
    M. Schmidt
    M. J. Battista
    Breast Cancer Research and Treatment, 2020, 182 : 389 - 399
  • [20] Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
    Andres Perroud, Herman
    Maria Alasino, Carlos
    Jose Rico, Maria
    Ernesto Mainetti, Leandro
    Queralt, Francisco
    Maris Pezzotto, Stella
    Rosa Rozados, Viviana
    Graciela Scharovsky, O.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (02) : 365 - 374
12345